NCT04419571

Brief Summary

NLR has previously been observed to correlate with complications in upper GI (1) and colorectal (2) surgery. The investigators sought to assess if a similar correlation can be identified in emergency general surgical patients and if the presence of suspected or confirmed COVID-19 may impact on this. Given the heterogeneity of emergency general surgery the investigators therefore plan to perform a retrospective review of patients having emergency laparotomies only at a single NHS site during COVID-19 pandemic. Assessment of outcomes and Neutrophil:lymphocyte ratio as a predictor of outcomes will be completed. Outcomes will be completed in line with the recent COVIDSurg study criteria (3). The primary outcome is 30-day mortality. Secondary outcomes are 7-day mortality, re-operation, length of stay, post-operative respiratory failure, post-operative ARDS (Acute Respiratory Distress Syndrome), post-operative sepsis and ITU (Intensive Therapy Unit)/HDU (High Dependency Unit) admission.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 23, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 5, 2020

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 16, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 16, 2020

Completed
Last Updated

July 23, 2020

Status Verified

July 1, 2020

Enrollment Period

3 months

First QC Date

June 4, 2020

Last Update Submit

July 22, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • 30-day mortality

    Mortality

    30 days

Secondary Outcomes (7)

  • 7-day mortality

    7 days

  • Number of participants returning to theatre

    30 days

  • Length of stay

    30 days

  • Post-operative respiratory failure

    30 days

  • Post-operative ARDS

    30 days

  • +2 more secondary outcomes

Other Outcomes (4)

  • Other complications

    30 days

  • Peri-operative NLR

    First 3 post-operative days

  • Post-operative platelet counts

    First 3 post-operative days

  • +1 more other outcomes

Study Arms (2)

Suspected or Confirmed COVID-19

All adult patients (\>17 years) undergoing emergency (laparotomy) surgery at a single centre (Queens Hospital, Romford, UK) with clinically or radiologically suspected COVID-19, or with viral PCR confirmation; diagnosis made 7-days before and 30-days after date of surgery in accordance with the COVIDsurg study criteria (3).

Procedure: Emergency Laparotomy

Negative or non-suspected COVID-19

All adult patients (\>17 years) undergoing emergency (laparotomy) surgery at a single centre (Queens Hospital, Romford, UK) without clinically or radiologically suspected COVID-19, or without viral PCR (Polymerase Chain Reaction) confirmation.

Procedure: Emergency Laparotomy

Interventions

All adult patients undergoing emergency laparotomy

Negative or non-suspected COVID-19Suspected or Confirmed COVID-19

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult patients (\>17 years) undergoing emergency (laparotomy) surgery at a single centre (Queens Hospital, Romford, UK) regardless of COVID-19 status will be included.

You may qualify if:

  • Patients undergoing emergency laparotomy (change made due to heterogeneity of emergency general surgery)

You may not qualify if:

  • Inherited or acquired immunodeficiency (which may directly skew NLR)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Queen's Hospital

Romford, RM7 0AG, United Kingdom

Location

Related Publications (2)

  • Vulliamy P, McCluney S, Mukherjee S, Ashby L, Amalesh T. Postoperative Elevation of the Neutrophil: Lymphocyte Ratio Predicts Complications Following Esophageal Resection. World J Surg. 2016 Jun;40(6):1397-403. doi: 10.1007/s00268-016-3427-z.

    PMID: 26813540BACKGROUND
  • Cook EJ, Walsh SR, Farooq N, Alberts JC, Justin TA, Keeling NJ. Post-operative neutrophil-lymphocyte ratio predicts complications following colorectal surgery. Int J Surg. 2007 Feb;5(1):27-30. doi: 10.1016/j.ijsu.2006.05.013. Epub 2006 Jun 27.

    PMID: 17386911BACKGROUND

Related Links

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

June 4, 2020

First Posted

June 5, 2020

Study Start

March 23, 2020

Primary Completion

June 16, 2020

Study Completion

June 16, 2020

Last Updated

July 23, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will share

All collected IPD regardless of inclusion in final publication

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Data will be available from completion of study for 10 years
Access Criteria
On request

Available IPD Datasets

Individual Participant Data Set (285260)Access
Statistical Analysis Plan (285260)Access
Study Protocol (285260)Access

Locations